Venetoclax combines synergistically with FLT3 inhibition to effectively target leukemic cells in FLT3-ITD+ acute myeloid leukemia models

FLT3 internal tandem duplication (FLT3-ITD) mutations account for ~25% of adult acute myeloid leukemia cases and are associated with poor prognosis. Venetoclax, a selective BCL-2 inhibitor, has limited monotherapy activity in relapsed/refractory acute myeloid leukemia with no responses observed in...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Raghuveer Singh Mali, Qi Zhang, RosaAnna DeFilippis, Antonio Cavazos, Vinitha Mary Kuruvilla, Jayant Raman, Vidhi Mody, Edna F. Choo, Monique Dail, Neil P. Shah, Marina Konopleva, Deepak Sampath, Elisabeth A. Lasater
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Ferrata Storti Foundation 2020-05-01
Reeks:	Haematologica
Online toegang:	https://haematologica.org/article/view/9753
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!